Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.27−0.15 (-10.56%)
Close on Nov 20, 2026Market cap $4.64MP/E –Yield –
Pulmatrix free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Pulmatrix's free cash flow for the twelve months ending Dec 31, 2024 was -$11.11M. For fiscal 2024 it was -$11.11M. The highest annual figure on record is $3.17M in fiscal 2019.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$11.11M | – |
| FY2023 | Dec 31, 2023 | -$16.66M | – |
| FY2022 | Dec 31, 2022 | -$19.44M | – |
| FY2021 | Dec 31, 2021 | -$19.87M | – |
| FY2020 | Dec 31, 2020 | -$12.76M | -502.4% |
| FY2019 | Dec 31, 2019 | $3.17M | – |
| FY2018 | Dec 31, 2018 | -$16.78M | – |
| FY2017 | Dec 31, 2017 | -$14.55M | – |
| FY2016 | Dec 31, 2016 | -$13.70M | – |
| FY2015 | Dec 31, 2015 | -$12.74M | – |
| FY2014 | Dec 31, 2014 | -$9.45M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$1.26M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.92M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.87M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.32M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.46M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.06M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.60M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.63M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.15M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.42M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.41M | -586.0% |
| Q4 FY2020 | Dec 31, 2020 | -$2.85M | – |
| Q3 FY2020 | Sep 30, 2020 | -$5.62M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.00M | -133.3% |
| Q1 FY2020 | Mar 31, 2020 | $702.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.44M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.94M | – |
| Q2 FY2019 | Jun 30, 2019 | $15.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.47M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.18M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.53M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.25M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.64M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.52M | – |
See a number that looks wrong?